MedPath

GH receptor polymorfism: the effects on growth hormone substitution in patients with growth hormone deficiency

Conditions
growth hormone deficiency
10021112
Registration Number
NL-OMON30312
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

- Informed consent
- All patients with growth hormone deficiency who have been treated with growth hormone substitution for at least one year

Exclusion Criteria

- Known pathogenic mutations in the growth hormone receptor that caused growth hormone deficiency.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath